Symbols / BFRI
BFRI Chart
About
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a common skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Drug Manufacturers - Spe | Market Cap | 9.07M |
| Enterprise Value | 10.55M | Income | -17.57M | Sales | 37.16M |
| Book/sh | -0.22 | Cash/sh | 0.29 | Dividend Yield | — |
| Payout | 0.00% | Employees | 92 | IPO | — |
| P/E | — | Forward P/E | -3.39 | PEG | — |
| P/S | 0.24 | P/B | -3.51 | P/C | — |
| EV/EBITDA | -0.60 | EV/Sales | 0.28 | Quick Ratio | 0.51 |
| Current Ratio | 1.15 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -1.50 | EPS next Y | -0.23 | EPS Growth | — |
| Revenue Growth | -22.50% | Earnings | 2026-03-20 17:00 | ROA | -64.91% |
| ROE | -11.92% | ROIC | — | Gross Margin | 64.41% |
| Oper. Margin | -89.84% | Profit Margin | -47.28% | Shs Outstand | 11.65M |
| Shs Float | 8.17M | Short Float | 1.24% | Short Ratio | 0.34 |
| Short Interest | — | 52W High | 1.19 | 52W Low | 0.54 |
| Beta | 0.63 | Avg Volume | 461.55K | Volume | 114.77K |
| Target Price | $6.00 | Recom | Strong_buy | Prev Close | $0.79 |
| Price | $0.78 | Change | -1.43% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$6.00
Mean price target
2. Current target
$0.82
Latest analyst target
3. DCF / Fair value
$-6.98
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.82
Low
$3.00
High
$9.00
Mean
$6.00
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-05-19 | main | Benchmark | Buy → Buy | $3 |
| 2024-11-15 | reit | Benchmark | Buy → Buy | $7 |
| 2024-08-16 | reit | Benchmark | Buy → Buy | $7 |
| 2023-08-31 | reit | Benchmark | Buy → Buy | $18 |
- Ameluz skin gel moves toward trunk-and-limb use after drug exposure study - Stock Titan ue, 17 Feb 2026 14
- Is Biofrontera Inc. (BFRI) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance hu, 05 Feb 2026 08
- There's No Escaping Biofrontera Inc.'s (NASDAQ:BFRI) Muted Revenues Despite A 42% Share Price Rise - simplywall.st Fri, 23 Jan 2026 08
- Light therapy gel clears more actinic keratoses on limbs, neck - Stock Titan Mon, 09 Feb 2026 14
- Biofrontera Inc. (BFRI) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Nasdaq hu, 05 Feb 2026 08
- What analysts say about BFRI stock - Rate Hike & Weekly Consistent Profit Watchlists - mfd.ru Sat, 14 Feb 2026 10
- PTA-Adhoc: Biofrontera AG: Forecast Increase - TradingView Sat, 14 Feb 2026 12
- Biofrontera stock holds Buy rating at Benchmark despite Q3 net loss - Investing.com Fri, 14 Nov 2025 08
- How BFRI stock performs in interest rate cycles - July 2025 Levels & Real-Time Stock Price Movement Reports - mfd.ru Sun, 15 Feb 2026 00
- Record $17M quarter for Biofrontera as Ameluz PDT sales climb higher - Stock Titan ue, 13 Jan 2026 08
- Why retail investors pile into BFRI stock - July 2025 Setups & Reliable Breakout Forecasts - mfd.ru Sun, 15 Feb 2026 18
- Biofrontera Inc. (NASDAQ:BFRI): When Will It Breakeven? - Yahoo Finance Sun, 28 Sep 2025 07
- Is BFRI stock overvalued or fairly priced - July 2025 Spike Watch & Consistent Return Investment Signals - mfd.ru Sun, 15 Feb 2026 21
- Why BFRI stock remains on watchlists - July 2025 Retail & Stock Market Timing Techniques - mfd.ru Wed, 11 Feb 2026 07
- What makes BFRI stock attractive to growth funds - July 2025 News Drivers & Consistent Return Strategy Ideas - mfd.ru Fri, 13 Feb 2026 03
Insider Transactions
| Date | Shares | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|
| 0 | 137500 | — | — | LUEBBERT HERMANN | Chief Executive Officer | — | 2025-09-10 00:00:00 | D |
| 1 | 87500 | — | — | LEFFLER EUGENE FREDERICK | Chief Financial Officer | — | 2025-09-10 00:00:00 | D |
| 2 | 4771 | — | — | LUEBBERT HERMANN | Chief Executive Officer | — | 2024-05-17 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 325.50K | 634.83K | 4.60M | -3.28M |
| TaxRateForCalcs | 0.21 | 0.21 | 0.21 | 0.27 |
| NormalizedEBITDA | -16.03M | -21.48M | -20.97M | -24.61M |
| TotalUnusualItems | 1.55M | 3.02M | 21.91M | -12.15M |
| TotalUnusualItemsExcludingGoodwill | 1.55M | 3.02M | 21.91M | -12.15M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -17.76M | -20.13M | -640.00K | -37.71M |
| ReconciledDepreciation | 1.15M | 1.06M | 1.17M | 540.00K |
| ReconciledCostOfRevenue | 18.61M | 17.44M | 15.19M | 12.74M |
| EBITDA | -14.48M | -18.45M | 934.00K | -36.76M |
| EBIT | -15.63M | -19.52M | -238.00K | -37.30M |
| NetInterestIncome | -2.08M | -560.00K | -203.00K | -344.00K |
| InterestExpense | 2.11M | 600.00K | 370.00K | 360.00K |
| InterestIncome | 71.00K | 132.00K | 175.00K | 16.00K |
| NormalizedIncome | -18.98M | -22.52M | -17.95M | -28.84M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -17.76M | -20.13M | -640.00K | -37.71M |
| TotalExpenses | 54.53M | 56.65M | 51.05M | 49.95M |
| TotalOperatingIncomeAsReported | -17.21M | -22.68M | -18.58M | -25.20M |
| DilutedAverageShares | 5.52M | 1.55M | 1.33M | 440.41K |
| BasicAverageShares | 5.52M | 1.55M | 1.33M | 440.41K |
| DilutedEPS | -3.22 | -13.02 | -0.48 | -85.60 |
| BasicEPS | -3.22 | -13.02 | -0.48 | -85.60 |
| DilutedNIAvailtoComStockholders | -17.76M | -20.13M | -640.00K | -37.71M |
| NetIncomeCommonStockholders | -17.76M | -20.13M | -640.00K | -37.71M |
| NetIncome | -17.76M | -20.13M | -640.00K | -37.71M |
| NetIncomeIncludingNoncontrollingInterests | -17.76M | -20.13M | -640.00K | -37.71M |
| NetIncomeContinuousOperations | -17.76M | -20.13M | -640.00K | -37.71M |
| TaxProvision | 22.00K | 14.00K | 32.00K | 56.00K |
| PretaxIncome | -17.74M | -20.12M | -608.00K | -37.66M |
| OtherIncomeExpense | 1.55M | 3.02M | 21.98M | -11.46M |
| OtherNonOperatingIncomeExpenses | -1.00K | -3.00K | 69.00K | 689.00K |
| SpecialIncomeCharges | -148.00K | 7.42M | 3.80M | 650.00K |
| OtherSpecialCharges | 148.00K | -7.52M | ||
| RestructuringAndMergernAcquisition | 0.00 | 100.00K | -3.80M | -650.00K |
| GainOnSaleOfSecurity | 1.70M | -4.40M | 18.11M | -12.80M |
| NetNonOperatingInterestIncomeExpense | -2.08M | -560.00K | -203.00K | -344.00K |
| TotalOtherFinanceCost | 41.00K | 92.00K | 8.00K | |
| InterestExpenseNonOperating | 2.11M | 600.00K | 370.00K | 360.00K |
| InterestIncomeNonOperating | 71.00K | 132.00K | 175.00K | 16.00K |
| OperatingIncome | -17.21M | -22.58M | -22.38M | -25.85M |
| OperatingExpense | 35.92M | 39.20M | 35.87M | 37.21M |
| ResearchAndDevelopment | 2.09M | 77.00K | 0.00 | |
| SellingGeneralAndAdministration | 33.84M | 39.13M | 35.87M | 37.21M |
| GeneralAndAdministrativeExpense | 39.13M | 35.87M | 37.21M | |
| OtherGandA | 39.13M | 35.87M | 37.21M | |
| GrossProfit | 18.71M | 16.63M | 13.49M | 11.36M |
| CostOfRevenue | 18.61M | 17.44M | 15.19M | 12.74M |
| TotalRevenue | 37.32M | 34.07M | 28.67M | 24.10M |
| OperatingRevenue | 37.32M | 34.07M | 28.67M | 24.10M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 8.87M | 1.52M | 1.33M | 855.24K |
| ShareIssued | 8.87M | 1.52M | 1.33M | 855.24K |
| NetDebt | 2.56M | |||
| TotalDebt | 4.92M | 5.40M | 1.35M | 0.00 |
| TangibleBookValue | 4.40M | 2.16M | 20.85M | 7.89M |
| InvestedCapital | 8.53M | 8.70M | 23.88M | 11.34M |
| WorkingCapital | 8.68M | 4.99M | 22.25M | 32.59M |
| NetTangibleAssets | 4.40M | 2.16M | 20.85M | 7.89M |
| CapitalLeaseObligations | 824.00K | 1.50M | 1.35M | 0.00 |
| CommonStockEquity | 4.43M | 4.79M | 23.88M | 11.34M |
| TotalCapitalization | 8.53M | 4.79M | 23.88M | 11.34M |
| TotalEquityGrossMinorityInterest | 4.43M | 4.79M | 23.88M | 11.34M |
| StockholdersEquity | 4.43M | 4.79M | 23.88M | 11.34M |
| RetainedEarnings | -117.41M | -99.65M | -79.52M | -78.88M |
| AdditionalPaidInCapital | 121.83M | 104.44M | 103.40M | 90.20M |
| CapitalStock | 9.00K | 2.00K | 1.00K | 17.00K |
| CommonStock | 9.00K | 2.00K | 1.00K | 17.00K |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 17.67M | 23.14M | 27.01M | 41.88M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 5.65M | 5.05M | 6.11M | 28.05M |
| OtherNonCurrentLiabilities | 23.00K | 37.00K | 21.00K | 5.65M |
| DerivativeProductLiabilities | 1.25M | 4.21M | 2.84M | 12.85M |
| NonCurrentDeferredLiabilities | 0.00 | 2.40M | 9.54M | |
| NonCurrentDeferredRevenue | 0.00 | 2.40M | 9.54M | |
| LongTermDebtAndCapitalLeaseObligation | 4.37M | 804.00K | 848.00K | 0.00 |
| LongTermCapitalLeaseObligation | 276.00K | 804.00K | 848.00K | 0.00 |
| LongTermDebt | 4.10M | |||
| CurrentLiabilities | 12.02M | 18.09M | 20.89M | 13.84M |
| OtherCurrentLiabilities | 613.00K | 686.00K | 372.00K | 829.00K |
| CurrentDeferredLiabilities | 0.00 | 6.94M | 3.24M | |
| CurrentDeferredRevenue | 0.00 | 6.94M | 3.24M | |
| CurrentDebtAndCapitalLeaseObligation | 548.00K | 4.59M | 498.00K | |
| CurrentCapitalLeaseObligation | 548.00K | 691.00K | 498.00K | 0.00 |
| CurrentDebt | 3.90M | |||
| OtherCurrentBorrowings | 3.90M | |||
| PensionandOtherPostRetirementBenefitPlansCurrent | 2.43M | 2.19M | 2.85M | 2.38M |
| CurrentProvisions | 58.00K | 149.00K | 82.00K | 246.00K |
| PayablesAndAccruedExpenses | 8.37M | 10.47M | 10.15M | 7.13M |
| CurrentAccruedExpenses | 1.17M | 1.47M | 7.56M | 6.20M |
| Payables | 7.20M | 9.01M | 2.59M | 940.00K |
| DuetoRelatedPartiesCurrent | 5.34M | 5.70M | 1.31M | 282.00K |
| AccountsPayable | 1.86M | 3.31M | 1.28M | 658.00K |
| TotalAssets | 22.10M | 27.93M | 50.88M | 53.22M |
| TotalNonCurrentAssets | 1.40M | 4.86M | 7.74M | 6.80M |
| OtherNonCurrentAssets | 383.00K | 482.00K | 320.00K | 268.00K |
| DuefromRelatedPartiesNonCurrent | 0.00 | 2.81M | 2.81M | |
| NonCurrentAccountsReceivable | 2.81M | 2.81M | ||
| GoodwillAndOtherIntangibleAssets | 35.00K | 2.63M | 3.03M | 3.45M |
| OtherIntangibleAssets | 2.63M | 3.03M | 3.45M | |
| NetPPE | 983.00K | 1.75M | 1.58M | 267.00K |
| AccumulatedDepreciation | -557.00K | -507.00K | -406.00K | |
| GrossPPE | 983.00K | 1.75M | 2.09M | 673.00K |
| Leases | 368.00K | 368.00K | 368.00K | |
| OtherProperties | 983.00K | 1.75M | 1.38M | |
| MachineryFurnitureEquipment | 323.00K | 343.00K | 305.00K | |
| Properties | 0.00 | 0.00 | 0.00 | |
| CurrentAssets | 20.70M | 23.07M | 43.14M | 46.42M |
| OtherCurrentAssets | 527.00K | 5.58M | 286.00K | 756.00K |
| AssetsHeldForSaleCurrent | 2.30M | 0.00 | ||
| PrepaidAssets | 305.00K | 524.00K | 973.00K | |
| Inventory | 6.65M | 10.91M | 7.17M | 4.46M |
| Receivables | 5.32M | 5.16M | 7.41M | 15.69M |
| OtherReceivables | 3.26M | |||
| DuefromRelatedPartiesCurrent | 0.00 | 3.66M | 8.65M | |
| AccountsReceivable | 5.32M | 5.16M | 3.75M | 3.78M |
| AllowanceForDoubtfulAccountsReceivable | -200.00K | -200.00K | -100.00K | -18.00M |
| GrossAccountsReceivable | 5.51M | 5.36M | 3.85M | 21.78M |
| CashCashEquivalentsAndShortTermInvestments | 5.91M | 1.42M | 27.76M | 24.55M |
| OtherShortTermInvestments | 7.00K | 78.00K | 10.55M | 0.00 |
| CashAndCashEquivalents | 5.91M | 1.34M | 17.21M | 24.55M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -10.33M | -24.90M | -16.24M | -26.73M |
| RepaymentOfDebt | -4.32M | -21.34M | ||
| IssuanceOfDebt | 4.05M | 25.25M | 0.00 | 0.00 |
| IssuanceOfCapitalStock | 7.66M | 4.51M | 9.39M | 29.94M |
| CapitalExpenditure | -60.00K | -5.00K | -38.00K | -11.00K |
| InterestPaidSupplementalData | 1.73M | 147.00K | 1.00K | 2.00K |
| IncomeTaxPaidSupplementalData | 24.00K | 15.00K | 32.00K | 56.00K |
| EndCashPosition | 6.11M | 1.54M | 17.41M | 24.74M |
| BeginningCashPosition | 1.54M | 17.41M | 24.74M | 8.28M |
| ChangesInCash | 4.56M | -15.87M | -7.33M | 16.46M |
| FinancingCashFlow | 14.84M | 8.41M | 14.02M | 43.19M |
| CashFlowFromContinuingFinancingActivities | 14.84M | 8.41M | 14.02M | 43.19M |
| ProceedsFromStockOptionExercised | 7.44M | 0.00 | 4.63M | 13.25M |
| NetPreferredStockIssuance | 7.66M | 0.00 | ||
| PreferredStockIssuance | 7.66M | 0.00 | ||
| NetCommonStockIssuance | 0.00 | 4.51M | 9.39M | 29.94M |
| CommonStockIssuance | 0.00 | 4.51M | 9.39M | 29.94M |
| NetIssuancePaymentsOfDebt | -265.00K | 3.90M | 0.00 | 0.00 |
| NetShortTermDebtIssuance | -265.00K | 3.90M | 0.00 | |
| ShortTermDebtPayments | -4.32M | -21.34M | ||
| ShortTermDebtIssuance | 4.05M | 25.25M | 0.00 | |
| NetLongTermDebtIssuance | 21.45M | 0.00 | 0.00 | |
| LongTermDebtIssuance | 21.45M | 0.00 | 0.00 | |
| InvestingCashFlow | -3.00K | 619.00K | -5.16M | -11.00K |
| CashFlowFromContinuingInvestingActivities | -3.00K | 619.00K | -5.16M | -11.00K |
| NetInvestmentPurchaseAndSale | 57.00K | 624.00K | -5.12M | 0.00 |
| SaleOfInvestment | 57.00K | 624.00K | 0.00 | |
| PurchaseOfInvestment | 0.00 | -5.12M | 0.00 | |
| NetIntangiblesPurchaseAndSale | -50.00K | 0.00 | ||
| PurchaseOfIntangibles | -50.00K | 0.00 | ||
| NetPPEPurchaseAndSale | -10.00K | -5.00K | -38.00K | -11.00K |
| PurchaseOfPPE | -10.00K | -5.00K | -38.00K | -11.00K |
| OperatingCashFlow | -10.27M | -24.89M | -16.20M | -26.71M |
| CashFlowFromContinuingOperatingActivities | -10.27M | -24.89M | -16.20M | -26.71M |
| ChangeInWorkingCapital | 6.21M | -4.39M | 2.79M | -1.50M |
| ChangeInOtherCurrentLiabilities | -689.00K | -657.00K | -781.00K | 0.00 |
| ChangeInOtherCurrentAssets | 5.16M | -5.16M | 0.00 | |
| ChangeInPayablesAndAccruedExpense | -2.04M | 64.00K | -2.69M | 11.71M |
| ChangeInAccruedExpense | -230.00K | -6.35M | -3.61M | 12.48M |
| ChangeInPayable | -1.81M | 6.42M | 912.00K | -773.00K |
| ChangeInAccountPayable | -1.81M | 6.42M | -773.00K | |
| ChangeInPrepaidAssets | -141.00K | 174.00K | 4.15M | -3.81M |
| ChangeInInventory | 4.23M | -3.75M | -2.81M | 2.59M |
| ChangeInReceivables | -313.00K | 4.93M | 4.92M | -12.00M |
| ChangesInAccountReceivables | -315.00K | -1.54M | -70.00K | -612.00K |
| OtherNonCashItems | 297.00K | -6.88M | -3.44M | -1.04M |
| StockBasedCompensation | 1.02M | 1.04M | 1.85M | 129.00K |
| UnrealizedGainLossOnInvestmentSecurities | 7.42M | -1.75M | 0.00 | |
| ProvisionandWriteOffofAssets | 162.00K | 122.00K | 206.00K | 77.00K |
| DepreciationAmortizationDepletion | 1.15M | 1.06M | 1.17M | 540.00K |
| DepreciationAndAmortization | 1.15M | 1.06M | 1.17M | 540.00K |
| AmortizationCashFlow | 329.00K | 418.00K | 418.00K | 418.00K |
| AmortizationOfIntangibles | 329.00K | 418.00K | 418.00K | 418.00K |
| Depreciation | 820.00K | 646.00K | 754.00K | 122.00K |
| OperatingGainsLosses | -1.35M | 4.28M | -16.39M | 12.80M |
| GainLossOnInvestmentSecurities | -1.67M | 4.28M | -16.39M | 12.80M |
| NetIncomeFromContinuingOperations | -17.76M | -20.13M | -640.00K | -37.71M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for BFRI
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|